Search results

    Search results

    Show all results for ""
    Can not find any results or suggestions for "."

    Search tips

    • Make sure there are no spelling errors
    • Try different search terms or synonyms
    • Narrow your search for more hits

    How can we help?

    Contact Us

    Find Employees

    University of Skövde, link to startpage
    University of Skövde, link to startpage
    Close

    Search results

      Search results

      Show all results for ""
      Can not find any results or suggestions for "."

      Search tips

      • Make sure there are no spelling errors
      • Try different search terms or synonyms
      • Narrow your search for more hits

      How can we help?

      Contact Us

      Find Employees

      University of Skövde, link to startpage

      Evaluation of new pharmaceutical compounds and their effects in the area of cancer and also in stroke

      Research Group Translational Medicine
      Resarch Environment Digital Health Research (DHEAR)

      Quick Facts

      Full project name

      The effect that Nox2 and Nox4 inhibitors have on cancer and stroke

      Duration

      January 2016 – December 2025

      Partners

      Financing

      Glucox Biotech AB

      Enzymatic inhibitors that slow down the production of ROS (reactive oxygen species) have been shown to be effective in mitigating the effects of a stroke. Additional effects, such as reduced growth of cancer cells have also been detected. This area of research is very exciting as no approved drugs with similar effects are available today.

      Project leader

      Senior Lecturer in Biomedicine

      Participating Researchers

      Published: 1/28/2020
      Edited: 1/28/2020
      Responsible: webmaster@his.se